BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 7, 2026
Home
»
Authors
» Aaron Lorenzo
Aaron Lorenzo
Articles
ARTICLES
Surface Logix Completes $25M Round For Drug Discovery Work
Nov. 27, 2002
By
Aaron Lorenzo
Biotech Veterans Bring In $13.6M To Fund Seattle-Based GeneCraft
Nov. 26, 2002
By
Aaron Lorenzo
Biotech Veterans Bring In $13.6M To Fund Seattle-Based GeneCraft
Nov. 26, 2002
By
Aaron Lorenzo
Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis
Nov. 22, 2002
By
Aaron Lorenzo
Inflazyme In Line For Up To $90M After Expanding Deal With Aventis
Nov. 22, 2002
By
Aaron Lorenzo
Inflazyme In Line For Up To $90M After Expanding Deal With Aventis
Nov. 22, 2002
By
Aaron Lorenzo
Inspire Starts Phase III Trial Of Drug For Allergic Rhinitis
Nov. 22, 2002
By
Aaron Lorenzo
Palatin Raises $11.5M For LeuTech, PT-141 Progress
Nov. 21, 2002
By
Aaron Lorenzo
Palatin Raises $11.5M For LeuTech, PT-141 Progress
Nov. 21, 2002
By
Aaron Lorenzo
Psychiatric Genomics Raises $17M As Part Of Series B Round
Nov. 20, 2002
By
Aaron Lorenzo
View All Articles by Aaron Lorenzo
